|Deal Watch: Gates bets $10M on Schrödinger||| Print ||
|Articles - June 2010|
Though it's true that Microsoft chairman Bill Gates met Richard Friesner, co-founder of the Portland-based scientific firm Schrödinger, while playing bridge, there's much more to Gates' recent $10 million investment in Schrödinger than a card game.
"That's something we can all smile about," says Shi-Yi Liu, vice president of marketing for Schrödinger, "but I think it's more fair to say that, as people get to know each other, there's a meeting of the minds and shared views about science and technology."
Founded in California in 1990 and relocated to Portland in 1995, Schrödinger specializes in pharmaceutical software that helps researchers simulate testing of drug compounds. The company, which tops the $20 million revenue mark, employs 140 people, including 40 in Portland.
Liu says the infusion, made through Gates' investment arm, Cascade Investment, will primarily help Schrödinger beef up its research and development staff. The end result: more accurate and better-performing software for new drug development.
Though some of the company's scientists are in Portland — along with the accounting, technical and scientific support and quality assurance departments — most research is done in Schrödinger's New York office, closer to scientific advisers and large commercial customers. That's likely to remain unchanged even with Gates' investment.
Because the drug development process can take more than 10 years and sometimes billions of dollars, Liu says there's not a specific drug that can yet be tied directly to Schrödinger. However, various companies have reached milestones in their drug development processes with Schrödinger's technology. Among its more well-known customers: Bayer HealthCare AG.
The Gates investment, Liu says, comes at an opportune time for Schrödinger and will ultimately provide researchers with more powerful tools in their search for new drugs. One such researcher: David Dawson, who is pursuing a cure for cystic fibrosis at Oregon Health & Science University.
"We're really making an investment in scientific research," Liu says. "We have many ambitious goals and we know where additional basic and advanced research efforts are needed. This investment will enable us to start to execute on that."
|Powerball jackpot hits new record|
|5.1-magnitude quake hits eastern Canada|
|How a Seattle school launched Bill Gates career|
|Windows Phone surpasses Blackberry|
|Kim Dotcom doesn't want 3D gun plans on Mega's servers|
|David Beckham retires from soccer|
|ODB, Eazy-E holograms to perform|
|Will this startup succeed?|
|The STEM shortage|
|Combined Transport keeps on trucking|
|Farm futures: private equity goes organic|
|Food cart owner Nong balances life, work and play|
|Celly launches its DIY network|
|What is driving the cost of health care? |
Oregon Business magazine's 5th annual
100 Best Green Companies to Work For in Oregon
Wednesday, May 29, 2013
From Oregon Translational Research and Development Institute: OTRADI today announced its plans to open and operate a 13,000 square-foot multi-tenant bioscience complex in the Willamette Wharf building at 4640 SW Macadam Avenue. Slated to be complete in spring 2013, the OTRADI Bioscience Incubator (OBI) will house up to six companies.
MEDIAmerica, publisher of Oregon Business and Oregon Home magazines, announces a new retail website: HalfOffOregon.com. The website offers lodging, dining, recreation and many other items at half off their regular cost.
As you probably know by now, The Vernon Company is a national leader in the promotional products industry with annual sales of over $60 million. We are a family owned business, led by the fourth generation of the Vernon family.